Compare CVBF & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CVBF | TLX |
|---|---|---|
| Founded | 1974 | 2015 |
| Country | United States | Australia |
| Employees | N/A | 1184 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.6B |
| IPO Year | 2009 | N/A |
| Metric | CVBF | TLX |
|---|---|---|
| Price | $22.46 | $10.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $24.50 | $21.13 |
| AVG Volume (30 Days) | ★ 1.5M | 202.9K |
| Earning Date | 04-22-2026 | 08-19-2026 |
| Dividend Yield | ★ 3.95% | N/A |
| EPS Growth | ★ 5.56 | N/A |
| EPS | ★ 0.38 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $21.47 | N/A |
| Revenue Next Year | $15.21 | N/A |
| P/E Ratio | ★ $59.11 | $150.33 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.95 | $6.28 |
| 52 Week High | $22.57 | $16.95 |
| Indicator | CVBF | TLX |
|---|---|---|
| Relative Strength Index (RSI) | 67.58 | 62.06 |
| Support Level | $18.20 | $9.46 |
| Resistance Level | N/A | $11.28 |
| Average True Range (ATR) | 0.49 | 0.28 |
| MACD | 0.16 | 0.17 |
| Stochastic Oscillator | 88.50 | 77.15 |
CVB Financial Corp is the holding company for Citizens Business Bank. Citizens Business Bank offers banking, lending, and investing services. It provides a full complement of lending products, including commercial, agribusiness, consumer, SBA, real estate, and construction loans, as well as equipment and vehicle leasing. Commercial products include lines of credit and other working capital financing, accounts receivable lending and letters of credit. It is a community bank with one reportable operating segment.
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.